These findings indicate that E2F1 specifically regulates ASH1L-AS1 transcription and APPLE expression to promote HCC progression through impacting ERK1/2 dephosphorylation and activating MAPK signaling (Fig. 8O). This evidence concerns the gene MAPK3 and hepatocellular carcinoma.